12 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... corticosteroid; FEV1: forced ... #Management #Pulmonary ... #LABA #ICS #Guidelines
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... receptor antagonists; LABA ... immunotherapy; FEV1: forced ... Management #Stepwise #Pulmonary ... #Algorithm #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... assessment test; FEV1, forced ... corticosteroid; LABA ... #Algorithm #Management ... #Pulmonary #LABA
Hyponatremia - Differential Diagnosis Algorithm
Hypovolemic - Give volume
Hypervolemic (Edematous) - Look for and treat underlying cause
underlying cause (CHF ... cirrhosis, nephrotic syndrome ... Stress, Nausea, Pulmonary ... Unremarkable Labs ... #Algorithm #diagnosis
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
- Differential Diagnosis ... Decompensated CHF ... • Obstructive: Pulmonary ... Abdominal compartment syndrome ... #criticalcare #algorithm
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... : • Labs: leukocytosis ... Imaging: CXR- pulmonary ... sepsis), PE, DAH, CHF
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... lab markers such ... acute coronary syndrome ... #table #foamed ... #heartfailure #chf
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
Syndromes - OnePager ... Renal Syndromes ... Labs: • BMP (quantify ... #Renal #Syndromes ... #management #treatment
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
that are poorly formed ... factor (GCSF) treatments ... marrow studies Treatment ... factors (examples: G-CSF ... #diagnosis #hematology
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... respiratory distress syndrome ... of lipid-laden 'foamy ... Labs: • Nonspecific ... macrophages Treatment